Market Tracker

06/23 5:16pm ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

15.80
Delayed Data
As of Jun 23
 +0.30 / +1.94%
Today’s Change
8.31
Today|||52-Week Range
32.74
+8.82%
Year-to-Date
Saba Capital Management, L.P. Buys Clough Global Opportunities Fund, General American...
Jun 20 / GuruFocus News - Paid Partner Content
Billionaire John Paulson Wants You to Buy Valeant -- Here's What the Chart Says
Jun 19 / TheStreet.com - Paid Partner Content
John Paulson Joins Valeant's Board During Trying Transition
Jun 20 / GuruFocus News - Paid Partner Content
Valeant Stock Jumps After John Paulson Is Named to Board
Jun 19 / TheStreet.com - Paid Partner Content
Company News for June 20, 2017
Jun 20 / Zacks.com - Paid Partner Content
Valeant (VRX) Down 4% Since Earnings Report: Can It Rebound?
Jun 14 / Zacks.com - Paid Partner Content
John Paulson Joins Valeant's Board to Aid in Trying Transition
Jun 20 / GuruFocus News - Paid Partner Content
Valeant Inks Deal to Divest iNova Pharmaceuticals for $930M
Jun 12 / Zacks.com - Paid Partner Content
John Paulson Joins Valeant's Board to Assist in Trying Transition
Jun 19 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close15.50
Today’s open15.35
Day’s range14.89 - 15.85
Volume37,840,381
Average volume (3 months)22,990,509
Market cap$5.3B
Dividend yield--
Data as of 4:02pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-716.47%
Earnings growth (this year)-33.38%
Earnings growth (next 5 years)-1.55%
Revenue growth (last year)-7.39%
P/E ratioNM
Price/Sales0.52
Price/Book1.71

Competitors

 Today’s
change
Today’s
% change
PTHNPatheon NV+0.05+0.14%
CTLTCatalent Inc-0.58-1.53%
GRFSGrifols SA-0.25-1.11%
CLVSClovis Oncology Inc-1.78-1.84%
Data as of 4:05pm ET, 06/23/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$0.96
Annual revenue (last year)$9.7B
Annual profit (last year)-$2.4B
Net profit margin-24.90%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive VP-Finance
Paul S. Herendeen
Corporate headquarters
Laval, Quă©bec

Forecasts